Terumo Medical Launches SurTract Safety Syringe In The United States

08 January 2026 | Thursday | News


The new retractable syringe integrates passive SafeR technology to improve injection safety, clinical reliability and ease of use while reducing needle injury risk and enhancing patient comfort across care settings.

 New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* − 

Terumo Medical Corporation, a wholly-owned subsidiary of Terumo  Corporation, announced the US launch of its SurTract™ Safety Syringe, powered by SafeR® passive safety  technology developed by Roncadelle Operations S.r.l. The SurTract Syringe will be distributed across  hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026. 

SafeR technology provides the SurTract Syringe with a fully passive, automatic retraction mechanism that  withdraws the needle into the plunger immediately after use – helping reduce the risk of needle-stick injuries  for physicians, and providing patients with a smooth and comfortable injection due to less plunger  pressure*. The syringe system also preserves standard clinical technique while offering enhanced safety,  reliability and ease of use. 

Other benefits include:  

  • A customizable needle selection designed for use exclusively with SurTract Syringes, allowing  physicians the opportunity to create the combination they need for optimal patient care. A blunt needle, preventing dullness and allowing a change of needle for drawing up aspiration. Less medical waste due to a lack of an external plastic safety sheath. 
  • Reduction in medication waste due to the low dead space syringe*. 

“The SurTract Syringe combines Terumo’s trusted clinical know-how with Roncadelle’s validated SafeR  technology to deliver a simple, effective solution for safer injections,” said Bob Klock, Vice President, Terumo  Medical Corporation. “It gives healthcare providers more – and better – treatment options for their patients,  which is our ultimate goal.” 

“Terumo has significantly advanced injection safety with the integration of our SafeR technology,” said Dr.  Fred Metzmann, Chief Business Development Officer at Roncadelle Operations. “Together, we are delivering  a next-generation syringe system that is intuitive, reliable, and engineered to protect healthcare  professionals.” 

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close